Jing Luan

1.1k total citations
40 papers, 819 citations indexed

About

Jing Luan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jing Luan has authored 40 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Jing Luan's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (6 papers) and Alzheimer's disease research and treatments (4 papers). Jing Luan is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (6 papers) and Alzheimer's disease research and treatments (4 papers). Jing Luan collaborates with scholars based in China, United States and France. Jing Luan's co-authors include Ying Xue, Chongliang Zhang, Binduo Xu, Yiping Ren, Xingchun Gou, Na Guo, Zhifang Hu, Xingchun Gao, Jianghong Cheng and Henri‐Jean Garchon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jing Luan

37 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Luan China 15 319 231 132 115 64 40 819
Kenta Fujimoto Japan 19 116 0.4× 359 1.6× 273 2.1× 72 0.6× 64 1.0× 57 901
Ye Chen United States 15 127 0.4× 277 1.2× 77 0.6× 73 0.6× 50 0.8× 43 949
Yujing Cao China 23 316 1.0× 526 2.3× 107 0.8× 74 0.6× 86 1.3× 68 1.4k
И. А. Черешнев Russia 19 175 0.5× 334 1.4× 164 1.2× 52 0.5× 87 1.4× 52 1.2k
Miki Takeuchi Japan 23 158 0.5× 645 2.8× 70 0.5× 196 1.7× 94 1.5× 41 1.1k
Keisuke Toyama Japan 14 205 0.6× 346 1.5× 61 0.5× 155 1.3× 26 0.4× 60 943
Fen Wei China 15 183 0.6× 267 1.2× 20 0.2× 63 0.5× 44 0.7× 45 750
Seung Hyeon Kim South Korea 18 257 0.8× 282 1.2× 48 0.4× 53 0.5× 61 1.0× 65 961
Lichun Wang China 18 301 0.9× 441 1.9× 43 0.3× 73 0.6× 72 1.1× 33 1.4k
Caterina Millino Italy 16 126 0.4× 490 2.1× 35 0.3× 59 0.5× 163 2.5× 27 892

Countries citing papers authored by Jing Luan

Since Specialization
Citations

This map shows the geographic impact of Jing Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Luan more than expected).

Fields of papers citing papers by Jing Luan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Luan. The network helps show where Jing Luan may publish in the future.

Co-authorship network of co-authors of Jing Luan

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Luan. A scholar is included among the top collaborators of Jing Luan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Luan. Jing Luan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Qin, Jianhua, Yao Zhang, Jing Luan, et al.. (2025). Disrupting mitochondrial dynamics attenuates ferroptosis and chemotoxicity via upregulating NRF2-mediated FSP1 expression. Cell Reports. 44(9). 116234–116234. 1 indexed citations
3.
Liu, Huan, et al.. (2024). E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway. Journal of Investigative Dermatology. 144(11). 2453–2464.e11. 3 indexed citations
4.
Sun, Na, et al.. (2024). Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4. Cell Death and Disease. 15(11). 861–861. 4 indexed citations
5.
Luan, Jing, et al.. (2024). Aged AβPPswe/PS1ΔE9 mice as a useful animal model for studying the link between immunological senescence and diseases. Immunology Letters. 266. 106842–106842. 1 indexed citations
7.
Zhou, Jiaqing, Jingjing Zhang, Tao Lü, et al.. (2022). Up-regulation of BTN3A1 on CD14 + cells promotes Vγ9Vδ2 T cell activation in psoriasis. Proceedings of the National Academy of Sciences. 119(44). e2117523119–e2117523119. 12 indexed citations
8.
Zhai, Cui, Nana Zhang, Jian Wang, et al.. (2022). Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation. Lung. 200(5). 619–631. 4 indexed citations
9.
Lao, Kejing, Ruisan Zhang, Yuxuan Dai, et al.. (2021). Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease. Molecular and Cellular Neuroscience. 114. 103630–103630. 6 indexed citations
10.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2020). The mechanism of propofol in cancer development: An updated review. Asia-Pacific Journal of Clinical Oncology. 16(2). e3–e11. 32 indexed citations
11.
Chen, Yanke, Jing Luan, Ting Jiang, et al.. (2020). Knockdown of EMMPRIN (OX47) in MRMT-1 Carcinoma Cells Inhibits Tumor Growth and Decreases Cancer-Induced Bone Destruction and Pain. Cancer Research and Treatment. 53(2). 576–583. 3 indexed citations
12.
Mi, Yajing, Na Guo, Jing Luan, et al.. (2020). The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment. Frontiers in Immunology. 11. 737–737. 106 indexed citations
13.
Luan, Jing, Kui Zhang, Yang Zhang, et al.. (2018). The combination of FK506 and an anti-CD147 mAb exerts potential therapeutic effects on a mouse model of collagen-induced arthritis. Molecular Immunology. 101. 1–9. 10 indexed citations
14.
Luan, Jing, Chongliang Zhang, Binduo Xu, Ying Xue, & Yiping Ren. (2018). Modelling the spatial distribution of three Portunidae crabs in Haizhou Bay, China. PLoS ONE. 13(11). e0207457–e0207457. 23 indexed citations
15.
Luan, Jing, Yu Zhao, Yang Zhang, et al.. (2017). CD147 blockade as a potential and novel treatment of graft rejection. Molecular Medicine Reports. 16(4). 4593–4602. 5 indexed citations
17.
Hu, Lili, Chen Sun, Jing Luan, Linlin Lu, & Shicui Zhang. (2015). Zebrafish phosvitin is an antioxidant with non-cytotoxic activity. Acta Biochimica et Biophysica Sinica. 47(5). 349–354. 12 indexed citations
18.
Liu, Zhenhui, Shicui Zhang, Hongyan Li, et al.. (2005). Characterization and expression profile ofAmphiCD63encoding a novel member of TM4SF proteins from amphioxusBranchiostoma belcheri tsingtauense. DNA sequence. 16(3). 195–201. 4 indexed citations
19.
Nanney, Lillian B., Alison Skeel, Jing Luan, et al.. (1998). Proteolytic Cleavage and Activation of pro-Macrophage-Stimulating Protein and Upregulation of its Receptor in Tissue Injury. Journal of Investigative Dermatology. 111(4). 573–581. 60 indexed citations
20.
Lamhamedi-Cherradi, Salah-Eddine, et al.. (1998). Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia. 41(2). 178–184. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026